Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To determine the efficacy of onartuzumab+erlotinib compared with placebo+erlotinib, as measured by progression-free survival (PFS) assessed by the investigator.
Critère d'inclusion
- non-small cell lung cancer